Effects of C5 complement inhibitor pexelizumab on outcome in high-risk coronary artery bypass grafting: Combined results from the PRIMO-CABG I and II trials
| Image |  |
|---|---|
| Description | scientific article published on September 28, 2010 |
| Author/s |
author: Jerrold Levy |
| Publication date | September 28, 2010 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |